April 16, 2025: Gastroparesis Is Central Issue as Parties Prepare for Hearing in Wegovy Lawsuit Many people who took Wegovy or other GLP-1 weight loss drugs suffered from gastroparesis, or gut paralysis, causing them to be hospitalized or even die from complications
Among the 14 trials included, four excluded patients with heart failure, while the remaining nine articles excluded patients with heart failure, cardiac events (e.g., myocardial infarction, unstable angina, revascularization procedure, stroke) or cardiovascular diseases ( Supplementary Table 4 )
This flexibility allows individuals to prioritize their health without disrupting their schedules
Based on these data, across all studies, few participants received rescue therapy (ranging approximately between 0.3% and 3.5% of participants), except for one study in which 25% of participants in the placebo arm required rescue therapy [22]
And its funny, I was talking about this on a different podcast a couple of weeks ago
Consideration of sex differences in design and reporting of experimental arterial pathology studies-statement from ATVB council